Stock ICLF MEDICO INTERCONTINENTAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medico Intercontinental Limited

Equities

ICLF

INE858Q01019

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 09:35:03 30/05/2024 am IST 		5-day change 1st Jan Change
47 INR +2.55% Intraday chart for Medico Intercontinental Limited +1.45% -49.43%
25/05 Medico Intercontinental Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
25/05 Medico Intercontinental Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 50.03 382.2 50.52 83.34 188.9 829.4
Enterprise Value (EV) 1 48.62 371.6 179.3 171.3 257.6 808.7
P/E ratio 170 x 51.9 x 2.14 x 3.23 x 6.1 x 14.8 x
Yield - - - - - 0.12%
Capitalization / Revenue 12.9 x 3.78 x 0.06 x 0.12 x 0.25 x 1.08 x
EV / Revenue 12.5 x 3.67 x 0.22 x 0.25 x 0.35 x 1.06 x
EV / EBITDA 98.2 x 36.6 x 4.07 x 3.45 x 4.83 x 14 x
EV / FCF - -4,74,22,168 x -13,63,725 x 57,82,828 x 97,43,419 x -71,32,829 x
FCF Yield - -0% -0% 0% 0% -0%
Price to Book 1.53 x 9.55 x 0.79 x 0.87 x 1.5 x 2.01 x
Nbr of stocks (in thousands) 3,249 3,249 3,249 3,249 3,249 10,000
Reference price 2 15.40 117.6 15.55 25.65 58.15 82.94
Announcement Date 10/10/18 26/08/19 10/08/20 06/09/21 05/09/22 06/06/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 3.891 101.1 820.1 697.7 743.2 765.3
EBITDA 1 0.4951 10.16 44.04 49.6 53.32 57.72
EBIT 1 0.463 10.13 43.05 48.28 51.3 55.72
Operating Margin 11.9% 10.02% 5.25% 6.92% 6.9% 7.28%
Earnings before Tax (EBT) 1 0.463 10.06 32.02 35.43 42.53 49.5
Net income 1 0.2947 7.36 23.57 25.76 31 36.08
Net margin 7.58% 7.28% 2.87% 3.69% 4.17% 4.71%
EPS 2 0.0907 2.265 7.254 7.929 9.540 5.612
Free Cash Flow - -7.835 -131.5 29.62 26.44 -113.4
FCF margin - -7.75% -16.03% 4.24% 3.56% -14.82%
FCF Conversion (EBITDA) - - - 59.7% 49.59% -
FCF Conversion (Net income) - - - 114.96% 85.31% -
Dividend per Share - - - - - 0.1000
Announcement Date 10/10/18 26/08/19 10/08/20 06/09/21 05/09/22 06/06/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 129 87.9 68.7 -
Net Cash position 1 1.41 10.7 - - - 20.7
Leverage (Debt/EBITDA) - - 2.925 x 1.773 x 1.289 x -
Free Cash Flow - -7.84 -132 29.6 26.4 -113
ROE (net income / shareholders' equity) 0.91% 20.2% 45.5% 32.4% 28% 13.4%
ROA (Net income/ Total Assets) 0.71% 9.71% 11.9% 9.05% 10.2% 7.67%
Assets 1 41.23 75.76 197.8 284.7 302.5 470.4
Book Value Per Share 2 10.10 12.30 19.60 29.30 38.90 41.20
Cash Flow per Share 2 0.5100 3.640 2.400 1.580 5.740 6.790
Capex - - 1.63 2.09 2.11 4.22
Capex / Sales - - 0.2% 0.3% 0.28% 0.55%
Announcement Date 10/10/18 26/08/19 10/08/20 06/09/21 05/09/22 06/06/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
MEDICO INTERCONTINENTAL LIMITED Stock Medico Intercontinental Limited
-50.69% 5.65M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+17.43% 42.25B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+15.37% 21.27B
SANDOZ GROUP AG Stock Sandoz Group AG
+16.67% 15.23B
CIPLA LIMITED Stock Cipla Limited
+19.84% 14.36B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+51.59% 12.74B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-12.40% 6.61B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+14.28% 5.66B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ICLF Stock
  4. Financials Medico Intercontinental Limited